Eli Lilly (LLY) Grew Revenue 48% While Prices Fell, Can Volume Keep Winning?
Eli Lilly (NYSE:LLY) reports third-quarter results in about a week, and the split between volume and price matters more than the headline total. In the second quarter, revenue rose 48% to $23.0 billion on a 60% jump in the amount of medicine sold, while the price Lilly collected per unit fell 13%. The company is […]
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo